Krebs Biochemicals and Industries Q1FY22 loss increases to Rs. 9.42 Cr

Krebs Biochemicals and Industries Q1FY22 loss increases to Rs. 9.42 Cr

By: ICN Bureau

Last updated : July 31, 2021 7:33 am



The company reported total income of Rs.6.78 crores during the period ended June 30, 2021.


Krebs Biochemicals and Industries has reported total income of Rs.6.78 crores during the period ended June 30, 2021 as compared to Rs.16.30 crores during the period ended March 31, 2021.

The company reported total income of Rs.11.61 crores during the period ended June 30, 2020.

The company has posted net loss of Rs.(9.42) crores for the period ended June 30, 2021 as against net lossof Rs.(6.98) crores for the period ended March 31, 2021.

It posted net loss of Rs.(6.72) crores for the period ended June 30, 2020.

Krebs Biochemicals and Industries

First Published : July 31, 2021 12:00 am